Info

EPIX Pharmaceuticals, Inc. (EPIX) is a biopharmaceutical company focused on discovering, developing and commercializing pharmaceutical products. EPIX has four internally discovered therapeutic product candidates in clinical trials. These drug candidates are PRX-00023 for depression, PRX-03140 for Alzheimer’s disease, PRX-08066 for pulmonary hypertension and PRX-07034 for cognitive impairment associated with Schizophrenia and Alzheimer’s disease. The Company's blood-pool imaging agent, Vasovist, is approved for marketing in more than 30 countries outside of the United States. The focus of EPIX's therapeutic drug discovery and development efforts is on the two classes of drug targets known as G-protein Coupled Receptors (GPCRs) and ion channels.(Source: 10-K)